Breaking News

You are here » Indian-Commodity  :  Top News  :  Zydus gets USFDA's nod for Candesartan Cilexetil, Hydrochlorothiazide Tablets

29-Nov2017

Zydus gets USFDA's nod for Candesartan Cilexetil, Hydrochlorothiazide Tablets

Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Candesartan Cilexetil and Hydrochlorothiazide Tablets USP in the strengths of 16 mg/12.5 mg, 32 mg/12.5 mg and 32 mg/25 mg. The drug combines an angiotensin II receptor (type ATI) antagonist and a diuretic, hydrochlorothiazide and is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.

The group now has more than 175 approvals and has so far filed over 310 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.



Related News

View all news

Gold futures trade higher on Monday

Gold futures traded higher on Monday, owing to increased safer asset investments amid receding concerns on global growth slowdown and worries on a potential US recession. Moreover, dimmer global market......

Turmeric futures trade higher on NCDEX

Turmeric futures traded higher on NCDEX on enlarged positions counting on uptick in demand for the crop in the physical market. However, new season arrivals and good production prospects, capped the upside......

Crude oil futures plunge on weak overseas cues

Crude oil futures plunged on MCX as speculators trimmed their position after tracking weak trend overseas amid worried about the prospect of a recession in the United States. The contract for April delivery......

Top News

View all news

Lupin receives USFDA's approval for Sildenafil Tablets

Lupin has received approval for its Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Pfizer Inc's Viagra Tablets,......

HCL features as leader in Everest Group's Cloud Enablement Services PEAK Matrix Assessment 2019

HCL Technologies (HCL) has been recognized as a leader in Everest Group's Cloud Enablement Services PEAK Matrix Assessment 2019. Everest Group assessed the global cloud enablement service providers and......

Time Technoplast bags order for supply of PE Pipes

Time Technoplast has secured an order for supply of High Quality, High Pressure PE Pipes for prestigious water supply project in India assisted by International Development Agencies. This order from India's......